Welcome, Guest |
TOPIC:
Expert Professor by email - September 13th 8 years 7 months ago #173
A few comments on the website and related generic initiative:
I do understand patients desperation * Comment - the site content has been corrected in line with point 2 YMMV | |
Expert Professor by email - September 13th 8 years 7 months ago #176
Hi Prof Wow point 2 is something that I'm still attempting to process. Having treated about 7 years ago with the older chemicals this is a concept I struggle to comprehend. 'Some being detectable at the end of treatment but go on to svr'. Obviously this research has been developed from the more recent DAA research, can you point us in the direction of this data? Em Geno 1b F2/3 snce early 80s. Treated in 2008_9 for 63 weeks on INF/Riba. Commence Sof/Dac on 6 October 2015 and completed 18 weeks of tx. UND at 4-6 weeks, UND at EOT, SVR 2, SVR 6 and SVR 12 on 6 May 2016. | |
Expert Professor by email - September 13th 8 years 7 months ago #177
Dr Freeman Point 2 has been a question in my mind for some time. I am glad to get a definitive answer on it, thanks. As you say, things are moving very fast in the hepc world. I seem to find out new info daily, and lately from this website which is turning out to be a very valuable source. dt | |
Expert Professor by email - September 13th 8 years 7 months ago #201
I have it on good authority: The information on end of treatment "detectable" HCV RNA and SVR was contained in presentations at EASL Conference in April, so not yet fully published. YMMV | |
Time to create page: 0.100 seconds